Review



fluorescein isothiocyanate fitc conjugated anti human cd14 61d3  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Thermo Fisher fluorescein isothiocyanate fitc conjugated anti human cd14 61d3
    Fluorescein Isothiocyanate Fitc Conjugated Anti Human Cd14 61d3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/Fluorescein/pm42177462-59-13-19
    Average 99 stars, based on 1 article reviews
    fluorescein isothiocyanate fitc conjugated anti human cd14 61d3 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Liquid Chromatography:

    Article Title: A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
    Article Snippet: .. Each sample was analyzed separately by microcapillary liquid chromatography (LC) with electrospray ionization coupled with tandem MS. We used a NanoAcquity LC System (Waters) with a 100-μm inner diameter × 10-cm length C18 analytical column (1.7 μm BEH130; Waters) configured with a 180-μm × 2-cm trap column coupled to a Q-Exactive Plus Mass PE-Cy7 clone 1D3 (eBioscience, 25-0193-81), anti-CD33-BV711 clone WM53 (BioLegend, 303423), and CD14-PE clone 61D3 (eBioscience, 12-0149-42). .. Pr20 or its human IgG1 isotype control (Eureka Therapeutics, ET901) was conjugated to APC using the lightning-link kit (Innova Bioscience, 705-0010), and staining was performed at 3 μg/ml, which was determined to be a saturating concentration.

    Recombinase Polymerase Amplification:

    Article Title: A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.
    Article Snippet: .. The following antibodies were used: CD45 clone Hl30 (eBioscience 47-0459-42), CD3e clone OKT3 (eBioscience 46-0037-42), HLA-DR clone L243 (eBioscience 48-9952-42), CD56 clone CMSSB (eBioscience 46-0567-42), CD56 clone HCD65 (BioLegend 318304), CD19 clone H1B19 (eBioscience 46-0198-42 and 56-0199-42), CD14 clone 61D3 (Invitrogen Q10056; Cohort 1), CD14 clone M5E2 (BioLegend 301836; Cohort 2), CD16 clone 3G8 (BioLegend 302040), CD11c clone 3.9 (eBioscience 56-0116-42), CD85g clone 17G10.2 (eBioscience 12-5179-42), BDCA-1 clone L161 (BioLegend 331516), BDCA-3 clone AD514H12 (Miltenyi 130-090-513), CD4 clone RPA-T4 (BioLegend 300550), CD8 clone RPA-T8 (BioLegend 301040), CD25 clone BC96 (BioLegend 302612), CD25 clone 2A3 (eBioscience 17-0259- 42), FOXP3 clone PCH101 (eBioscience 77-5776-40), FOXP3 clone 236 A/E7 (eBioscience 25-4777-42), PD-1 clone EH-12 (BioLegend 329930), CTLA-4 clone BNI3 (BioLegend 369606), γ δ T cell receptor (TCR) clone B1.1 (BioLegend 331212) and FLT3L (Abcam ab9688). ..

    Article Title: Circulating T cell-monocyte complexes are markers of immune perturbations
    Article Snippet: Key resources table Reagent type (species) or resource Designation Source or reference Identifiers Additional information Antibody CCR7-PerCpCy5.5; clone G043H7; mouse monoclonal Biolegend Cat# 353220 1:50 (4 ml per test) Antibody CD2-BV421; clone RPA-2.10; mouse monoclonal Biolegend Cat# 300229 1:66 (3 ml per test) Antibody CD3-AF700; clone UCHT1; mouse monoclonal BD pharmigen Cat# 557943 1:66 (3 ml per test) Antibody CD3-AF488; clone UCHT1; mouse monoclonal Biolegend Cat# 300415 1:200 (1 ml per test) Antibody CD4-APCeF780; clone RPA-T4; mouse monoclonal eBiosciences Cat# 47-0049-42 1:200 (1 ml per test) Antibody CD5-APCCy7; clone L17F12; mouse monoclonal Biolegend Cat# 364009 1:66 (3 ml per test) Continued on next page Burel et al. eLife 2019;8:e46045. .. DOI: https://doi.org/10.7554/eLife.46045 13 of 21 Continued Reagent type (species) or resource Designation Source or reference Identifiers Additional information Antibody CD7-APC; clone CD7-6B7; mouse monoclonal Biolegend Cat# 343107 1:66 (3 ml per test) Antibody CD8a-BV650; clone RPA-T8; mouse monoclonal Biolegend Cat# 301042 1:200 (1 ml per test) Antibody CD14-APC; clone 61D3; mouse monoclonal Tonbo biosciences Cat# 20–0149 T100 1:200 (1 ml per test) Antibody CD14-AF594; clone HCD14 Biolegend Cat# 325630 1:200 (1 ml per test) Antibody CD14-AF647; clone 63D3 Biolegend Cat# 367128 1:200 (1 ml per test) Antibody CD14-BV421; clone HCD14 Biolegend Cat# 325628 1:200 (1 ml per test) Antibody CD14-PE; clone 61D3; mouse monoclonal eBioscience Cat# 12-0149-42 1:200 (1 ml per test) Antibody CD27-BV650; clone O323 Biolegend Cat# 302827 1:100 (2 ml per test) Antibody CD33-APC; clone WM53 Biolegend Cat# 303407 1:200 (1 ml per test) Antibody CD36-APCCy7; clone 5–271 Biolegend Cat# 336213 1:100 (2 ml per test) Antibody CD45-PerCpCy5.5; clone HI30; mouse monoclonal Tonbo biosciences Cat# 65–0459 T100 1:66 (3 ml per test) Antibody CD45RA-eF450; clone HI100; mouse monoclonal eBiosciences Cat# 48-0458-42 1:200 (1 ml per test) Antibody CD64-AF488; clone 10.1; mouse monoclonal Biolegend Cat# 305010 1:200 (1 ml per test) Antibody CD163-PECy7; clone GHI/61; mouse monoclonal Biolegend Cat# 333613 1:100 (2 ml per test) Antibody ICAM1(CD54); unconjugated; clone HCD54; mouse monoclonal Biolegend Cat# 322704 1:40 (5 ml per test) Antibody LFA1(CD11a); unconjugated; clone TS2/4; mouse monoclonal Biolegend Cat# 350602 1:40 (5 ml per test) Antibody LFA1(CD11a/CD18)-AF647; clone m24; mouse monoclonal Biolegend Cat# 363412 1:40 (5 ml per test) .. Samples from TB uninfected individuals were obtained from the University of California, San Diego Antiviral Research Center clinic (AVRC at UCSD, San Diego) and National Blood Center (NBC), Ministry of Health, Colombo, Sri Lanka, in an anonymous fashion as previously described (Burel et al., 2017).

    other:

    Article Title: Microbially-Induced Exosomes from Dendritic Cells Promote Paracrine Immune Senescence: Novel Mechanism of Bone Degenerative Disease in Mice
    Article Snippet: Antibodies used: anti-human CD45R0 PerCP-eFluor 710; clone UCHL1 (ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#46-0457-41), anti-human CD27 eFluor 450; clone 0323 (ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#48-0279-42), anti-human IgD FITC; clone IA6-2 (ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#11-9868-42), anti-human CD57 PE Cyanine7; clone TB01(ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#25-0577-42), anti-human CD14 eFluor 450; clone 61D3 (ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#48-0149-42), anti-human CD3 PerCP Vio700; clone BW264/56 (Miltenyi Biotech Auburn, CA, USA; Cat #130-097-582), anti-human CD3 FITC; clone BW264/56 (Miltenyi Biotech Auburn, CA, USA; Cat #130-080-401), anti-human CD45RA VioGreen (Miltenyi Biotech Auburn, CA, USA; Cat#130-098-184), anti-human CD4 VioBlue; clone VIT4 (Miltenyi Biotech Auburn, CA, USA#130-098-163), anti-human CD16 VioGreen (Miltenyi Biotech Auburn, CA, USA; Cat#130-098-095), anti-human CD28 FITC; clone CD28.2 (ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#11-0289-42), anti-human CD8a PE; clone OKT8 (ebioscience, Thermofisher Scientific, Waltham MA, USA; Cat#12-0086-42), anti-human CD19 PE (BD Biosciences; Cat #555413), anti-human CD4 VioBlue (Miltenyi Biotech Auburn, CA, USA; Cat#130-099-683).

    Article Title: Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
    Article Snippet: The following directly conjugated antibodies were used to identify cell markers of monocytes in human PBMCs and in vitro cultured human CD14 + monocytes: mouse anti-human CD45-V450 at 1:100 dilution (HI30, BD Biosciences, 560367), mouse anti-human CD11B-BV510 at 1:100 dilution (ICRF44, BD Biosciences, 563088), mouse anti-human CD16-BV650 at 1:100 dilution (BD Biosciences, 563692), mouse anti-human CD56-BV786 at 1:100 dilution (BD Biosciences, 564058), mouse anti-human HLA-DR-PerCP-Cy5.5 at 1:100 dilution (G46-6, BD Biosciences, 560652), mouse anti-human CD19-PE-TR at 1:200 dilution (HIB19, eBioscience, 61-0199-42), mouse anti-human CD3-APC at 1:100 dilution (UCHT1, BD Biosciences, 555335), mouse anti-human CD14-APC-H7 at 1:100 dilution (MφP9, BD Biosciences, 560180), mouse anti-human CD86-BV711 (2331, BD Biosciences, 563158) and mouse anti-human TNF Alexa Fluor 700 at 1:100 dilution (MAb11, BD Biosciences, 557996).

    Functional Assay:

    Article Title: Bacterial lipoproteins induce distinct IL-8 inductions relying on their lipid moieties in pulmonary epithelial cells
    Article Snippet: All specific inhibitors for MAPKs were obtained from Calbiochem (La Jolla, CA, USA). .. Functional grade monoclonal antibodies for blocking TLR2 (TL2.1), CD14 (61D3) and TLR4 (HTA125) and their matching isotype antibodies were purchased from eBioscience (San Diego, CA, USA). .. CD25 antibody was purchased from BD Bioscience (clone 2A3).

    Bioprocessing:

    Article Title: Bacterial lipoproteins induce distinct IL-8 inductions relying on their lipid moieties in pulmonary epithelial cells
    Article Snippet: All specific inhibitors for MAPKs were obtained from Calbiochem (La Jolla, CA, USA). .. Functional grade monoclonal antibodies for blocking TLR2 (TL2.1), CD14 (61D3) and TLR4 (HTA125) and their matching isotype antibodies were purchased from eBioscience (San Diego, CA, USA). .. CD25 antibody was purchased from BD Bioscience (clone 2A3).

    Blocking Assay:

    Article Title: Bacterial lipoproteins induce distinct IL-8 inductions relying on their lipid moieties in pulmonary epithelial cells
    Article Snippet: All specific inhibitors for MAPKs were obtained from Calbiochem (La Jolla, CA, USA). .. Functional grade monoclonal antibodies for blocking TLR2 (TL2.1), CD14 (61D3) and TLR4 (HTA125) and their matching isotype antibodies were purchased from eBioscience (San Diego, CA, USA). .. CD25 antibody was purchased from BD Bioscience (clone 2A3).



    Similar Products

    99
    Thermo Fisher fluorescein isothiocyanate fitc conjugated anti human cd14 61d3
    Fluorescein Isothiocyanate Fitc Conjugated Anti Human Cd14 61d3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/Fluorescein/pm42177462-59-13-19
    Average 99 stars, based on 1 article reviews
    fluorescein isothiocyanate fitc conjugated anti human cd14 61d3 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    93
    Cytek Biosciences 50 0149 t025 61d3 igg1 κ tonbo biosciences
    50 0149 T025 61d3 Igg1 κ Tonbo Biosciences, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/PE+Anti-Human+CD14/pmc12579220__41420_2025_2786_MOESM1_ESM-81-63-68
    Average 93 stars, based on 1 article reviews
    50 0149 t025 61d3 igg1 κ tonbo biosciences - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher monoclonal antibody (61d3)
    Monoclonal Antibody (61d3), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/cd14+antibody/pmc12274847-76-0-7
    Average 90 stars, based on 1 article reviews
    monoclonal antibody (61d3) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd14 monoclonal antibody (61d3) apc-efluortm 780
    Cd14 Monoclonal Antibody (61d3) Apc Efluortm 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/cd14+antibody/pmc12274847-88-4-7
    Average 90 stars, based on 1 article reviews
    cd14 monoclonal antibody (61d3) apc-efluortm 780 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd14 pe-cy5 61d3 antibody
    Cd14 Pe Cy5 61d3 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/cd14+antibody/pmc09631623__advancesADV2021006720___suppl1-12-11-14
    Average 90 stars, based on 1 article reviews
    cd14 pe-cy5 61d3 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-human cd14-percp-cy5.5 clone 61d3
    Anti Human Cd14 Percp Cy5.5 Clone 61d3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/cd14+antibody/pm40651713-98-66-71
    Average 90 stars, based on 1 article reviews
    anti-human cd14-percp-cy5.5 clone 61d3 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-human cd14 alexa fluortm 700 (clone 61d3)
    Validation of immunophenotyping studies and dysregulated humoral immune response in German cohort 2. (a) German Cohort 2: description of cohort and experimental plan using matched PBMCs and serum from pregnant healthy controls (Preg-HC) and COVID-19 recovered (Preg-R) pregnant women. (b) Reduced percentage of <t>CD14</t> + monocytes and significantly increased CD14 + CD16 + in Preg-R patients. Box plots show median, interquartile range (IQR), and the whiskers corresponding to the highest and lowest points within 1.5 times of IQR. Each dot represents an individual sample. Wilcoxon rank-sum test was used for p-value significance to compare pregnant healthy control (Preg-HC) and COVID-19 recovered (Preg-R). P ≤0.05 considered significant (*p ≤0.05). (c) Box and whisker plot representing the percentage of Naïve, CM, EM I, and EM II CD8 + T cells in Preg-HC and Preg-R patients. CD8 + Naïve and CD8 + CM T cells were lower in Preg-R. CD8 + EM I and CD8 + EM II T cells were significantly increased Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (d) Box and whisker plot representing NKT cells in Preg-R compared with Preg-HC. (e) Box and whisker’s plot showing reduced CD56 + NK cells and CD56 + CD16 + NK II cells in Preg-R. Increased levels of CD56 - HLA-DR + lymphoid cells were significantly increased in Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (f) High levels of Nucleocapsid IgG antibody levels in serum of Preg-R group compared to Preg-HC (left graph). Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). Spike S1 (middle graph) and RBD IgG concentration (ug/mL; right graph) at different collection time-points (CT) points (CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection) during their pregnancy. Decreased levels of Spike S1 and RBD IgG antibodies 89 days post first collection time point in Preg-R group. Each dot represents an individual. Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05). (g) Examination of IL-10, MCP-1, and IL-8 levels in the serum of recovered women up to 89 days post infection. Each dot represents an individual on a box-whisker plot. CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection-during their pregnancy Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001).
    Anti Human Cd14 Alexa Fluortm 700 (Clone 61d3), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/anti+cd14/pmc12257036-12-0-8
    Average 90 stars, based on 1 article reviews
    anti-human cd14 alexa fluortm 700 (clone 61d3) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd14-pe-cy7 61d3 antibody
    Validation of immunophenotyping studies and dysregulated humoral immune response in German cohort 2. (a) German Cohort 2: description of cohort and experimental plan using matched PBMCs and serum from pregnant healthy controls (Preg-HC) and COVID-19 recovered (Preg-R) pregnant women. (b) Reduced percentage of <t>CD14</t> + monocytes and significantly increased CD14 + CD16 + in Preg-R patients. Box plots show median, interquartile range (IQR), and the whiskers corresponding to the highest and lowest points within 1.5 times of IQR. Each dot represents an individual sample. Wilcoxon rank-sum test was used for p-value significance to compare pregnant healthy control (Preg-HC) and COVID-19 recovered (Preg-R). P ≤0.05 considered significant (*p ≤0.05). (c) Box and whisker plot representing the percentage of Naïve, CM, EM I, and EM II CD8 + T cells in Preg-HC and Preg-R patients. CD8 + Naïve and CD8 + CM T cells were lower in Preg-R. CD8 + EM I and CD8 + EM II T cells were significantly increased Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (d) Box and whisker plot representing NKT cells in Preg-R compared with Preg-HC. (e) Box and whisker’s plot showing reduced CD56 + NK cells and CD56 + CD16 + NK II cells in Preg-R. Increased levels of CD56 - HLA-DR + lymphoid cells were significantly increased in Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (f) High levels of Nucleocapsid IgG antibody levels in serum of Preg-R group compared to Preg-HC (left graph). Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). Spike S1 (middle graph) and RBD IgG concentration (ug/mL; right graph) at different collection time-points (CT) points (CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection) during their pregnancy. Decreased levels of Spike S1 and RBD IgG antibodies 89 days post first collection time point in Preg-R group. Each dot represents an individual. Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05). (g) Examination of IL-10, MCP-1, and IL-8 levels in the serum of recovered women up to 89 days post infection. Each dot represents an individual on a box-whisker plot. CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection-during their pregnancy Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001).
    Cd14 Pe Cy7 61d3 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/cd14+antibody/pmc12111939-229-5-7
    Average 90 stars, based on 1 article reviews
    cd14-pe-cy7 61d3 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse anti-human cd14, alexa fluor 700, clone 61d3
    Validation of immunophenotyping studies and dysregulated humoral immune response in German cohort 2. (a) German Cohort 2: description of cohort and experimental plan using matched PBMCs and serum from pregnant healthy controls (Preg-HC) and COVID-19 recovered (Preg-R) pregnant women. (b) Reduced percentage of <t>CD14</t> + monocytes and significantly increased CD14 + CD16 + in Preg-R patients. Box plots show median, interquartile range (IQR), and the whiskers corresponding to the highest and lowest points within 1.5 times of IQR. Each dot represents an individual sample. Wilcoxon rank-sum test was used for p-value significance to compare pregnant healthy control (Preg-HC) and COVID-19 recovered (Preg-R). P ≤0.05 considered significant (*p ≤0.05). (c) Box and whisker plot representing the percentage of Naïve, CM, EM I, and EM II CD8 + T cells in Preg-HC and Preg-R patients. CD8 + Naïve and CD8 + CM T cells were lower in Preg-R. CD8 + EM I and CD8 + EM II T cells were significantly increased Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (d) Box and whisker plot representing NKT cells in Preg-R compared with Preg-HC. (e) Box and whisker’s plot showing reduced CD56 + NK cells and CD56 + CD16 + NK II cells in Preg-R. Increased levels of CD56 - HLA-DR + lymphoid cells were significantly increased in Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (f) High levels of Nucleocapsid IgG antibody levels in serum of Preg-R group compared to Preg-HC (left graph). Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). Spike S1 (middle graph) and RBD IgG concentration (ug/mL; right graph) at different collection time-points (CT) points (CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection) during their pregnancy. Decreased levels of Spike S1 and RBD IgG antibodies 89 days post first collection time point in Preg-R group. Each dot represents an individual. Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05). (g) Examination of IL-10, MCP-1, and IL-8 levels in the serum of recovered women up to 89 days post infection. Each dot represents an individual on a box-whisker plot. CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection-during their pregnancy Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001).
    Mouse Anti Human Cd14, Alexa Fluor 700, Clone 61d3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/anti+cd14/pmc12146614-20-7-9
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd14, alexa fluor 700, clone 61d3 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd14, apc-efluor 780, 61d3 antibody

    Cd14, Apc Efluor 780, 61d3 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/61d3/cd14+antibody/pmc12032839-3-3-5
    Average 90 stars, based on 1 article reviews
    cd14, apc-efluor 780, 61d3 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Validation of immunophenotyping studies and dysregulated humoral immune response in German cohort 2. (a) German Cohort 2: description of cohort and experimental plan using matched PBMCs and serum from pregnant healthy controls (Preg-HC) and COVID-19 recovered (Preg-R) pregnant women. (b) Reduced percentage of CD14 + monocytes and significantly increased CD14 + CD16 + in Preg-R patients. Box plots show median, interquartile range (IQR), and the whiskers corresponding to the highest and lowest points within 1.5 times of IQR. Each dot represents an individual sample. Wilcoxon rank-sum test was used for p-value significance to compare pregnant healthy control (Preg-HC) and COVID-19 recovered (Preg-R). P ≤0.05 considered significant (*p ≤0.05). (c) Box and whisker plot representing the percentage of Naïve, CM, EM I, and EM II CD8 + T cells in Preg-HC and Preg-R patients. CD8 + Naïve and CD8 + CM T cells were lower in Preg-R. CD8 + EM I and CD8 + EM II T cells were significantly increased Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (d) Box and whisker plot representing NKT cells in Preg-R compared with Preg-HC. (e) Box and whisker’s plot showing reduced CD56 + NK cells and CD56 + CD16 + NK II cells in Preg-R. Increased levels of CD56 - HLA-DR + lymphoid cells were significantly increased in Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (f) High levels of Nucleocapsid IgG antibody levels in serum of Preg-R group compared to Preg-HC (left graph). Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). Spike S1 (middle graph) and RBD IgG concentration (ug/mL; right graph) at different collection time-points (CT) points (CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection) during their pregnancy. Decreased levels of Spike S1 and RBD IgG antibodies 89 days post first collection time point in Preg-R group. Each dot represents an individual. Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05). (g) Examination of IL-10, MCP-1, and IL-8 levels in the serum of recovered women up to 89 days post infection. Each dot represents an individual on a box-whisker plot. CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection-during their pregnancy Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001).

    Journal: Frontiers in Immunology

    Article Title: Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women

    doi: 10.3389/fimmu.2025.1560391

    Figure Lengend Snippet: Validation of immunophenotyping studies and dysregulated humoral immune response in German cohort 2. (a) German Cohort 2: description of cohort and experimental plan using matched PBMCs and serum from pregnant healthy controls (Preg-HC) and COVID-19 recovered (Preg-R) pregnant women. (b) Reduced percentage of CD14 + monocytes and significantly increased CD14 + CD16 + in Preg-R patients. Box plots show median, interquartile range (IQR), and the whiskers corresponding to the highest and lowest points within 1.5 times of IQR. Each dot represents an individual sample. Wilcoxon rank-sum test was used for p-value significance to compare pregnant healthy control (Preg-HC) and COVID-19 recovered (Preg-R). P ≤0.05 considered significant (*p ≤0.05). (c) Box and whisker plot representing the percentage of Naïve, CM, EM I, and EM II CD8 + T cells in Preg-HC and Preg-R patients. CD8 + Naïve and CD8 + CM T cells were lower in Preg-R. CD8 + EM I and CD8 + EM II T cells were significantly increased Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (d) Box and whisker plot representing NKT cells in Preg-R compared with Preg-HC. (e) Box and whisker’s plot showing reduced CD56 + NK cells and CD56 + CD16 + NK II cells in Preg-R. Increased levels of CD56 - HLA-DR + lymphoid cells were significantly increased in Preg-R. Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). (f) High levels of Nucleocapsid IgG antibody levels in serum of Preg-R group compared to Preg-HC (left graph). Wilcoxon rank-sum test was used for p-value significance. P ≤0.05 considered significant (*p ≤0.05). Spike S1 (middle graph) and RBD IgG concentration (ug/mL; right graph) at different collection time-points (CT) points (CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection) during their pregnancy. Decreased levels of Spike S1 and RBD IgG antibodies 89 days post first collection time point in Preg-R group. Each dot represents an individual. Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05). (g) Examination of IL-10, MCP-1, and IL-8 levels in the serum of recovered women up to 89 days post infection. Each dot represents an individual on a box-whisker plot. CT1, 0 day; CT2, 39 days; and CT3, 89 days post infection-during their pregnancy Kruskal–Wallis test, adjusted for Dunn’s multiple comparisons test. P ≤0.05 considered significant (*p ≤0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001).

    Article Snippet: Anti-Human CD14 Alexa FluorTM 700 (clone 61D3) , Thermo Fisher Scientific (eBioscienceTM) , Cat#56-0149-42.

    Techniques: Biomarker Discovery, Control, Whisker Assay, Concentration Assay, Infection

    Journal: Cell reports

    Article Title: Distinct features of a peripheral T helper subset that drives the B cell response in dengue virus infection

    doi: 10.1016/j.celrep.2025.115366

    Figure Lengend Snippet:

    Article Snippet: CD14, APC-eFluor 780, 61D3 , eBioscience , Cat# 47-0149-42; RRID: AB_1834358.

    Techniques: Purification, Virus, Recombinant, Lysis, Staining, Electron Microscopy, Enzyme-linked Immunospot, Enzyme-linked Immunosorbent Assay, Amplification, Gene Expression, Software